ABSTRACT SERPINE2, one of the potent serine protease inhibitors that modulates the activity of plasminogen activator and thrombin, is implicated in many biological processes. In the present study, we purified SERPINE2 from mouse seminal vesicle secretion (SVS), using liquid chromatography and identified it by liquid chromatography/tandem mass spectrometry, and it showed potent inhibitory activity against the urokinase-type plasminogen activator. SERPINE2 was expressed predominantly in seminal vesicles among murine male reproductive tissues. It was immunolocalized to the SVS and mucosal epithelium of the seminal vesicle, epididymis, coagulating gland, and vas deferens. In the testes, SERPINE2 was immunostained in spermatogonia, spermatocytes, spermatids, Leydig cells, and spermatozoa. SERPINE2 was also detected on the acrosomal cap of testicular and epididymal sperm and was suggested to be an intrinsic sperm surface protein. The purified SERPINE2 protein could bind to epididymal sperm. A prominent amount of SERPINE2 was detected on ejaculated and oviductal spermatozoa. Nevertheless, SERPINE2 was detected predominantly on uncapacitated sperm, indicating that SERPINE2 is lost before initiation of the capacitation process. Moreover, SERPINE2 could inhibit in vitro bovine serum albumin-induced sperm capacitation and prevent sperm binding to the egg, thus blocking fertilization. It acts through preventing cholesterol efflux, one of the initiation events of capacitation, from the sperm. These findings suggest that the SERPINE2 protein may play a role as a sperm decapacitation factor.
INTRODUCTION
SERPINE2, also known as glia-derived nexin or protease nexin-1, belongs to the serine protease inhibitor (SERPIN) superfamily. It has broad antiprotease activity specific to serine proteases, including trypsin, thrombin, plasmin, and urokinasetype plasminogen activator (PLAU) [1] . It is widely expressed in various tissues, whereas the highest levels are found in seminal vesicles [2] .
The seminal vesicle is a male accessory sexual gland found in many mammalian species, which secretes a fluid called seminal vesicle secretion (SVS). SVS contributes a major portion to the liquid part of seminal plasma, which is a complex biological fluid formed from a mixture of secretions from various male reproductive tissues. It was found that removal of the seminal vesicle from mice and rats greatly reduced their fertility [3, 4] , demonstrating the importance of SVS to male fertility.
Proteins from seminal plasma interact with sperm by modifying the sperm surface membrane, an essential process in maintaining sperm viability, thus modulating their functions [5] . The existence of decapacitation factors, which are removed from the sperm head surface during the capacitation process and are able to reverse sperm capacitation, in seminal plasma has been known for more than 50 years [6] . Since the discovery of their existence, many proteins have been suggested to be decapacitation factors; however, their functions have not been fully characterized. In humans, some potential decapacitation factors that have been reported are glycodelin-S [7] , semenogelin I [8] , a 130-kDa glycoprotein [9] , and some mannosyl glycopeptides [10] . Several potential decapacitation factors of rodents were also identified, including a 40-kDa glycoprotein [11] , phosphatidylethanolamine-binding protein 1 (PEBP1) [12] ; three epididymal proteins, a cysteine-rich secretory protein 1 [13] , an acrosome-stabilizing factor [14] , and an epididymis-specific secretory protein, HongrES1 (symbol not official) [15, 16] ; and three secreted seminal vesicle proteins, SVA [17] , SVS2 [18, 19] , and SPINKL [20] .
Attempts have also been made to reveal other murine SVS proteins, which are involved in modulating sperm physiology. For example, a carcinoembryonic antigen-related cell adhesion molecule (CEACAM10) [21] and SVS7 [22] were found to enhance sperm motility. A kazal-type serine protease inhibitor (SPINK3), named P12, is able to suppress Ca 2þ uptake by sperm [23] . Recently, the secreted LY6 protein (SSLP-1) was found to be expressed predominantly in SVS [24] , although its function is unclear. However, other important components of the SVS remain to be identified. Further investigation of the SVS proteome may enhance our understanding of normal and abnormal male reproductive physiology.
The Serpine2 gene knockout causes abnormal alterations in SVS components, which may result in an imbalance between PLAU, expressed in seminal vesicles [25] , and SERPINE2. Thus, the vaginal plug becomes soft and shortened after mating and eventually impairs male fertility [26] . However, Pang et al. [3] found that removal of the coagulating glands, resulting in the absence of a vaginal plug, did not seem to explain the reduced fertility, which indicates that seminal vesicles may contribute certain factors to modulate fertility. Therefore, in addition to having a role in balancing the activity of proteases, SERPINE2 may also play a role in male reproduction. Although SERPINE2 was detected in portions of male reproductive tissues [2, 27] , the comprehensive expression patterns and functions of SERPINE2 in the male reproductive tract have not been characterized. We therefore purified this protein from the seminal vesicle to delineate its protein distribution in the male reproductive system and to study its effects on sperm function.
MATERIALS AND METHODS

Animals
Specific pathogen-free outbred ICR mice were purchased from BioLASCO Taiwan (Taipei, Taiwan). The animals were bred based on the technology derived from Charles River Laboratories (Wilmington, MA) and were maintained in the Animal Center at the Department of Medical Research, Mackay Memorial Hospital, and were treated according to institutional guidelines for the care and use of experimental animals. They were housed under controlled lighting (12L:12D) at 21-228C and provided with water and NIH-31 laboratory chow ad libitum.
Protein Purification and Analysis
Adult male mice (10-12 weeks old) were killed by cervical dislocation. The SVS was successively collected, centrifuged, and fractionated by ion-exchange chromatography using a diethylaminoethyl Sephacel (GE Healthcare Life Sciences, Piscataway, NJ) column and gel filtration with a Sephadex G-75 (GE Healthcare Life Sciences) column as previously described [24] . The potential SERPINE2-containing peak II eluted from the Sephadex G-75 column was further subjected to a heparin Sepharose 6 Fast Flow (2.6-3 10-cm) column (GE Healthcare Life Sciences) preequilibrated with 0.1 M Tris-HCl, 0.01 M sodium citrate, and 0.225 M NaCl (pH 7.4). After the nonretarded fractions were washed out, the column was eluted with 0.5 M NaCl in 0.1 M Tris-HCl and 0.01 M sodium citrate at pH 7.4 at a flow rate of 0.5 ml/min; fractions (2 ml) were collected, and absorbance records are shown in Figure 1A . The protein concentration was determined using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL). The N-glycoconjugate was removed from a glycoprotein using a PNGase F kit (New England Biolabs, Beverly, MA) following the manufacturer's instructions.
Protein Identification by Mass Spectrometry
Purified protein was resolved by SDS-PAGE on a 10% slab gel (8.2 3 7.3 3 0.075 cm). Protein bands on the SDS gel were excised and subjected to in-gel digestion with trypsin following our previously described method [20] . In brief, the gel was washed in a solution of 50% (v/v) acetonitrile and 100 mM NH 4 HCO 3 and digested by trypsin overnight at 378C. The tryptic peptides were then extracted with a solution of 60% (v/v) acetonitrile and 1% (v/v) trifluoroacetic acid (TFA), lyophilized, resuspended in 0.1% (v/v) TFA, and analyzed by liquid chromatography/tandem mass spectrometry (LC-MS/MS) equipped with an 1100 series HPLC unit (Agilent Technologies, Palo Alto, CA) and an LTQ FT hybrid mass spectrometer (Thermo Electron, San Jose, CA). MS/MS data were used for protein identification, using MASCOT search engine software (http://www.matrixscience.com), based on the International Protein Index databases (http://www.ebi.ac.uk/IPI).
Activity Assay
The inhibitory activity of SERPINE2 toward PLAU (also named uPA) was assayed using a uPA colorimetric assay kit (Millipore, Billerica, MA) according to the manufacturer's protocol. In brief, 5 lg of purified SERPINE2 protein was incubated with 5 units of PLAU for 1 h at 378C. Subsequently, assay buffer and chromogenic substrate were added and incubated for 30 min at 378C. The absorbance was read at 405 nm.
Antibody Production and Usage
Antisera against SERPINE2 were produced using New Zealand white rabbits. Purified SERPINE2 protein in normal saline (0.4 mg/ml) was emulsified with Freund's complete adjuvant (1:1, v/v). In total, 2 ml of the mixture was subcutaneously injected in multiple sites in individual rabbits. Two rabbits were boosted twice every 3 weeks with the mixture of the same amount of purified protein and Freund's incomplete adjuvant (1:1, v/v). Antisera were collected 10 days after the last injection.
Purified SERPINE2 protein (200 lg) was conjugated to AminoLink beads (Pierce) according to the manufacturer's instructions. Antisera against SERPINE2 were adsorbed by the conjugated beads to remove the specific antibody against SERPINE2. The treated antiserum was used as the control antiserum.
Antisera were also used to develop a custom-made sandwich-style ELISA kit by Taiwan Advanced Bio-Pharm (Taipei, Taiwan). The kit was used to estimate the SERPINE2 protein concentration in SVS, which was collected separately from 6 male mice at the age of 12 weeks.
Western Blotting
Proteins were resolved using SDS-PAGE on a 10% slab gel (8.2 3 7.3 3 0.075 cm) and stained with Coomassie Brilliant blue or transferred to a nitrocellulose membrane for immunostaining according to previously described methods [28] . Membranes were blocked with 10% (w/v) skim milk in PBS (blocking solution) for 2 h and then incubated with anti-SERPINE2 antiserum or control antiserum (1:8000 dilution) in blocking solution for 1 h at room temperature. After gentle agitation over four changes of PBS for 10 min each, membranes were immunoreacted with horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) (GE Healthcare Life Sciences) diluted to 1:10 000 in blocking solution for 1 h. Immunoreactive bands were revealed using an enhanced chemiluminescence substrate according to the manufacturer's instructions (Pierce).
Immunohistochemical Staining of the Accessory Gland of Male Mice
Murine (;12 weeks old) reproductive tissues were collected, fixed in formalin, embedded in paraffin, and cut into 5-lm sections. After the slides were deparaffinized and hydrated, they were placed in a plastic slide holder filled with antigen retrieval AR-10 solution (BioGenex, San Ramon, CA), soaked in a 708C water bath, rapidly boiled to .958C, and maintained for 15 min. While cooling to room temperature for 30 min, the slides were treated with 3% (v/v) H 2 O 2 in PBS for 15 min, blocked with 10% (v/v) normal goat serum in PBS (blocking solution) for 1 h at room temperature, and then incubated with anti-SERPINE2 antiserum or the control antiserum diluted 1:1000 in the blocking solution at 48C for 16 h. After slides were washed, they were treated with biotin-conjugated goat anti-rabbit IgG (;3 lg/ml) (Zymed Laboratories, South San Francisco, CA) in blocking solution for 1 h at room temperature. Slides were washed again and then incubated with HRP-conjugated streptavidin (;1 lg/ml) (Zymed Laboratories) in blocking solution for 40 min at room temperature. Protein signals were detected by 3-amino-9-ethylcarbazole staining (Zymed Laboratories). Slides were then counterstained with hematoxylin (Vector Laboratories, Burlingame, CA) and photographed using an Olympus BX 40 microscope (Olympus, Tokyo, Japan) equipped with an Olympus DP-70 digital camera.
Preparation of Spermatozoa
Epididymides and testes were immediately removed after male mice (;12 weeks old) were killed. Caudal epididymides were slit in prewarmed Biggers, Whitten, and Whittingham (BWW) medium [29] and incubated at 378C in 5% CO 2 for 15 min to allow motile sperm to swim upward. Motile sperm in the upper layer were collected. The caput and corpus regions of epididymides were treated in the same method as described above but were gently filtered through a 70-lm nylon cell strainer (BD Falcon, Franklin Lakes, NJ) to remove debris. For testicular sperm preparations, we referred to a previously described method [30] . In brief, testes were decapsulated by cutting the tunica albuginea to expose seminiferous tubules. An 18-gauge needle was used to aspirate the seminiferous tubules and push them through. The dispersed seminiferous SERPINE2 IS A POSSIBLE DECAPACITATION FACTOR 515 tubules were cut into pieces and filtered through a 70-lm nylon cell strainer (BD Falcon) to collect the free seminiferous cells.
To isolate ejaculated uterine and oviductal sperm, female mice (6 weeks old) were induced to superovulate by an intraperitoneal injection of 10 IU of equine chronic gonadotropin (China Chemical and Pharmaceutical, Hsinchu, Taiwan), followed by an intraperitoneal injection of 10 IU of human chorionic gonadotropin (China Chemical and Pharmaceutical) 48 h later, and were subsequently mated with male mice (;16 weeks old). Female mice with plugged vaginas were killed, and the ejaculated sperm in the uterine cavity were collected within 1 h. In brief, the semen filtered through a 70-lm nylon cell strainer (BD Falcon) was repeatedly agitated by pipetting with PBS. The sperm solution was washed by centrifuging it three times at 100 3 g for 10 min. Sperm were then fixed using 4% (w/v) paraformaldehyde in an Eppendorf tube for 20 min at room temperature, transferred onto slides, and allowed to dry. Oviductal sperm were collected the next day after mating by flushing the oviduct with PBS. Sperm were transferred using a mouth pipette onto slides and fixed in 4% (w/v) paraformaldehyde for subsequent immunostaining analysis.
Immunolocalization of SERPINE2 on Spermatozoa
To determine whether SERPINE2 protein is originally a sperm-binding protein, freshly prepared epididymal and testicular spermatozoa were fixed using 4% (w/v) paraformaldehyde and allowed to dry on a glass slide and washed twice with PBS. After slides were incubated in blocking solution of PBS containing 10% (v/v) normal goat serum for 1 h at room temperature, they were incubated with anti-SERPINE2 antiserum or control antiserum at a dilution of 1:100 in blocking solution for 1 h. The slides were washed three times with PBS to remove excess antibodies before they were incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Vector Laboratories) diluted 1:500 in blocking solution for 40 min. All slides were then washed with PBS and counterstained with 5 lg/ml Hoechst 33258 stain.
After three brief rinses with PBS, the slides were mounted in ;100 ll of ProLong Gold antifade medium (Invitrogen Molecular Probes, Eugene, OR) and photographed using an epifluorescence microscope (Olympus BX 40) equipped with an Olympus DP-70 digital camera.
To determine whether exogenous SERPINE2 protein can bind to epididymal sperm, 0.5 lM SERPINE2 was incubated with living sperm in Eppendorf tubes for 20 min at 378C. Unbound SERPINE2 protein was washed away by centrifuging the sperm in the PBS solution at 100 3 g for 5 min at room temperature. Sperm were then fixed using 4% (w/v) paraformaldehyde in an Eppendorf tube for 20 min at room temperature, transferred onto slides, and allowed to dry. Immunostaining was done as described above, except a dilution of 1:1000 was used for anti-SERPINE2 antiserum and control antiserum. The same dilution was also used to examine SERPINE2 on ejaculated and oviductal sperm, without incubation with the exogenous SERPINE2 protein.
To examine the correlation between SERPINE2-bound sperm and sperm capacitation, oviductal sperm were double-fluorescence-labeled by using indirect immunofluorescence and chlortetracycline (CTC) fluorescence staining, an empirical method used to morphologically assess sperm capacitation [31, 32] . In brief, sperm slides were washed twice with PBS and incubated in blocking solution, as mentioned above, for 1 h at room temperature. Then the slides were incubated with anti-SERPINE2 antiserum or control antiserum at a dilution of 1:1000 in blocking solution for 1 h. After slides were washed three times with PBS, they were incubated with tetramethyl rhodamine isothiocyanate (TRITC)-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA) diluted 1:200 in blocking solution for 40 min. All slides were then washed with PBS and counterstained with 5 lg/ml Hoechst 33258. After three brief rinses with PBS, the sperm on the slides were stained with a CTC solution prepared as previously described [31, 32] by incubation at 48C overnight and photographed using an epifluorescence microscope (Olympus BX 40) equipped with an Olympus DP-70 digital camera. 
Evaluation of Sperm Capacitation and the Acrosome Reaction
The molecular basis of sperm capacitation was examined by detecting any capacitation-accompanied increase in protein tyrosine phosphorylation of a subset of proteins with molecular weights of 40 000-120 000, according to a previously described method [33] . In brief, about 5 3 10 6 spermatozoa/ml was incubated in modified Krebs-Ringer bicarbonate medium [34] with or without bovine serum albumin (BSA) (3 mg/ml), as the positive or negative control, respectively, or BSA replaced with SERPINE2 at 378C in an atmosphere of 5% (v/v) CO 2 in humidified air for 90 min. To assess the effect of SERPINE2 on BSA-induced capacitation, SERPINE2 was preincubated with sperm under the above-described conditions for 20 min, and BSA was added thereafter. Then, the soluble fraction of sperm protein extracts was subjected to SDS-PAGE on an 8% slab gel. Proteins on the gel were electrotransferred onto nitrocellulose paper. Western blot analyses were performed using an anti-phosphotyrosine antibody according to a method described previously [33] .
To evaluate sperm capacitation by the CTC fluorescence-staining method, freshly prepared epididymal spermatozoa (10 6 cells/ml) were capacitated in 50 ll of BWW medium with or without BSA (3 mg/ml) as the positive or negative control, respectively, at 378C in an atmosphere of 5% (v/v) CO 2 in humidified air for 90 min. Medium was supplemented with SERPINE2 as described above, or the BSA was replaced with SERPINE2 to analyze the effects of SERPINE2 on sperm capacitation in vitro. CTC staining of sperm was carried out following the original method and examined using a fluorescence microscope (BX 40 model; Olympus).
To analyze the sperm acrosome reaction, the capacitated sperm, prepared as described above, were treated with 5 lM A23187 in dimethyl sulfoxide (DMSO) (0.2%) at 378C for 30 min. Sperm were smeared on the slide and fixed with methanol for 30 sec. The sperm acrosomal status was assessed by staining samples with 5 lg/ml TRITC-conjugated peanut agglutinin lectin (PNA; Sigma-Aldrich, St. Louis, MO) in the dark for 5 min and by counterstaining with 5 lg/ml Hoechst 33258. After three brief rinses in PBS, slides were mounted in 50 ll of ProLong Gold antifade medium (Invitrogen Molecular Probes) and immediately examined with a fluorescence microscope (BX 40; Olympus).
Sperm-Egg Binding and In Vitro Fertilization
Epididymal sperm (2 3 10 5 cells/ml) in 150 ll of BWW medium under mineral oil with or without BSA and/or SERPINE2 were capacitated for 90 min at 378C in an atmosphere of 5% (v/v) CO 2 in humidified air. Oocytecumulus complexes collected by superovulation treatment, as described above, were added to the same medium. For the sperm-egg binding assay, treated sperm were inseminated with oocyte-cumulus complexes for 30 min and then gently transferred using a mouth pipette with a bore approximately 1.53 the diameter of the oocyte to 70 ll of PBS under mineral oil. After allowing specimens to sit at room temperature for 5 min, the loosely bound sperm were detached, and the tightly bound sperm on the oocyte were counted using a Zeiss Axiovert 100 microscope (Zeiss, Oberkochen, Germany).
For in vitro fertilization, after 6 h of insemination, oocytes were washed with BWW medium, using a mouth pipette, fixed onto a slide with 4% (w/v) paraformaldehyde, and stained in 5 lg/ml Hoechst 33258 for 3 min. Slides were observed with a fluorescence microscope (BX 40; Olympus). Twopronuclei embryos were scored as fertilized.
Cholesterol Efflux Assay
Cholesterol content in the BWW medium with or without BSA (3 mg/ ml) and/or SERPINE2 (0.2 mg/ml) was assayed following the protocol described by Roberts et al. [13] . Freshly prepared epididymal spermatozoa (2 3 10 5 cells/ml) was capacitated in 150 ll of BWW medium as described above. After incubation, sperm were centrifuged at 10 000 3 g to separately collect the supernatant and sperm pellets. Samples were mixed with chloroform and methanol in a chloroform-methanol-supernatant (or -sperm) final ratio of 2:2:1.8. After vigorous vortexing, the mixture was centrifuged at 600 3 g for 5 min, and the organic phase was transferred to a new Eppendorf tube and dried by speed vacuum. The cholesterol content was measured using an Amplex Red cholesterol assay kit (Invitrogen Molecular Probes) according the manufacturer's instructions. To calculate the cholesterol content of the samples, a cholesterol standard curve was prepared using the cholesterol reference standard provided with the kit.
Statistical Analysis
Data are presented as means 6 SD. Differences were analyzed by one-way ANOVA, followed by the Bonferroni post hoc test using InStat software (GraphPad, San Diego, CA). A P value of ,0.05 was considered significant.
RESULTS
Purification and Identification of SERPINE2 from Mouse SVS
To prepare SERPINE2 for functional analyses and antibody production, we prefractionated SVS by ion exchange and gel filtration chromatography (see Materials and Methods). The possible SERPINE2-containing fraction, based on the molecular mass, was further purified to homogeneity using a heparin Sepharose column (Fig. 1A, peak II) , as SERPINE2 is a heparin-binding protein [35] . The purity of the resulting protein was shown with SDS-PAGE (Fig. 1B) . To identify this protein, the bands on the gel were excised and digested in-gel with trypsin, and the resulting tryptic peptides were subjected to LC-MS/MS analysis. Results showed that the purified protein had significant homology to SERPINE2, with the tryptic peptides matching 41%-43% of the protein sequences (Fig. 1C) . The purified SERPINE2 protein showed potent inhibitory activity against PLAU (Fig. 1D) , indicating that the purification procedures were not harmful to its protease-inhibitory activity. The SERPINE2 protein concentration in the SVS was estimated to be 0.6-0.8 mg/ml by the ELISA method.
Distribution of SERPINE2 Protein in Adult Male Mouse Reproductive Tissues
To study the tissue distribution of SERPINE2 protein in male reproductive tissues, we examined tissue homogenates, including the seminal vesicle, epididymis, testis, coagulating gland, vas deferens, and prostate, by Western blotting. The antibody against SERPINE2 recognized the purified 45-kDa 518 band and at least three forms, 40-, 42-, and 45-kDa proteins, from thousands of protein components in the tissue extract (Fig. 2) . In addition, high-molecular-weight proteins were also detected in protein extract from the testes. These proteins may be aggregated forms as no signal was seen (data not shown) when the antiserum was removed from the blots and samples were reprobed with the antiserum that was pretreated with SERPINE2-conjugated beads (control antiserum), indicating the high specificity of the antibody.
When protein database searching was conducted using Basic Local Alignment Search Tool (BLAST) algorithms (http://www.ncbi.nlm.nih.gov/BLAST) against a nonredundant database, using the SERPINE2 protein sequence (Swiss-Prot Q07235) as the query, three isoforms were revealed, with accession numbers gbjEDL16269.1j, gbjEDL16267.1j, and gbjEDL16268.1j. The theoretical molecular masses of the three isoforms were 30.812, 35.668, and 44.206 kDa, respectively. This was not processed by a signal peptidase. Thus, the mature protein would have the smaller molecular mass. However, the three proteins recognized by the anti-SERPINE2 antiserum had greater molecular masses, indicating they might be the glycosylated forms. In fact, SERPINE2 expression was demonstrated as two forms of glycoproteins [36] . However, when we treated the protein extract from seminal vesicles with N-glycosidase F, only the 45-kDa protein was found to be deglycosylated.
To reveal the cell types and subcellular compartments among male reproductive tissues that expressed the SERPINE2 protein, an immunolocalization study was conducted using the specific anti-SERPINE2 antiserum. The SERPINE2 protein 
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was immunolocalized to epithelial cells of seminal vesicles, coagulating glands, vas deferens, and caput or caudal epididymides (Fig. 3, B-E and G) . However, when slides were immunostained with control antiserum, no signal was detected (Fig. 3A) . Signals on corpus epididymides and the prostate were relatively weaker (Fig. 3, F and H) . The most prominent expression was found in the luminal fluid of seminal vesicles of adult mice. A signal on smooth muscle cells of seminal vesicles was also visible (Fig. 3B) . Interestingly, SERPINE2 protein was identified on spermatogonia, spermatocytes, spermatids, Leydig cells, and spermatozoa (Fig. 3I) , as revealed by the control slide treated with control antiserum (Fig. 3J) .
Binding of the SERPINE2 Protein to Spermatozoa
A visible SERPINE2 protein signal was prominently present on sperm in the lumen of the vas deferens and caudal epididymides (Fig. 3, D and G) . To verify binding of the SERPINE2 protein onto sperm, sperm isolated from testes or epididymides were smeared on slides, as shown in the phasecontrast image for comparison (Fig. 4A, a) . When slides were immunostained by control antiserum and an FITC-conjugated secondary antibody, no fluorescent signal was detected (Fig.  4A, b) . In contrast, SERPINE2 was detected on the acrosomal caps of caput, corpus, and caudal epididymal sperm by using the anti-SERPINE2 antiserum (Fig. 4A, c-e) . Likewise, apparent SERPINE2 protein signals were also visualized on the acrosomal cap of testicular sperm (Fig. 4A, f) . These results suggested that the SERPINE2 protein is an intrinsic surface protein of sperm during spermiogenesis and sperm maturation.
Exogenous SERPINE2 can apparently bind to caudal epididymal sperm, as demonstrated by incubation of the epididymal sperm with purified SERPINE2. The signal from this binding was so strong that it was prominently detected by a more-dilute anti-SERPINE2 antiserum (1:1000) (Fig. 4B, b) . The binding was strong on the acrosomal cap and on the tails of living epididymal sperm. Under the same detection conditions, epididymal sperm showed only a very faint intrinsic SER-PINE2 signal (Fig. 4B, a) . Although faint, the intrinsic signal, as mentioned above, was detected using more highly concentrated antiserum (1:100) (Fig. 4A, e) .
The SERPINE2 protein derived from seminal plasma was also detected on ejaculated and oviductal sperm (Fig. 4C, b and d, respectively) as demonstrated by control slides stained with control antiserum (Fig. 4C, a and c, respectively) . The binding was strong on the acrosomal cap but weaker on the tail. These findings indicate that the exogenous SERPINE2 may be a sperm surface protein in vivo.
Removal of SERPINE2 from Capacitated Sperm in the Oviduct
To determine whether capacitated or uncapacitated sperm have a SERPINE2-binding zone, oviductal sperm were immunostained with anti-SERPINE2 antiserum, and then the same sperm were fluorescently stained with CTC. As shown in Figure 5 , four staining types (Fig. 5, A-D ) of sperm were found. Staining type A was defined as capacitated sperm without SERPINE2 on the acrosome; type B was uncapacitated sperm with SERPINE2 on the head; type C was capacitated sperm with less SERPINE2 on the head; and type D was uncapacitated sperm with no SERPINE2 on the sperm surface. About 40% of the SERPINE2-bound sperm was the uncapacitated B type, but only about 10% of the capacitated type C sperm was seen in the oviduct. In addition, about 50% of the sperm in the oviduct were capacitated and not bound by SERPINE2. Interestingly, SERPINE2 was prominently present on uncapacitated sperm. It seems that SERPINE2 was released 
Effects of SERPINE2 on Sperm Function In Vitro
To examine the effects of SERPINE2 on epididymal sperm capacitation, we assessed the protein tyrosine phosphorylation pattern of epididymal sperm after incubation with BSA and/or SERPINE2. As shown in Figure 6A , only a few sperm proteins were phosphorylated in control medium without supplementation with BSA or SERPINE2 (Fig. 6A, lane 1) . However, BSA induced sperm capacitation accompanied by tyrosine phosphorylation of a group of proteins with a pattern similar to that found in previous studies (Fig. 6A, lane 2) [33] . The SERPINE2 protein prominently decreased the phosphorylation of the control medium (Fig. 6A, lane 3) . In addition, the extent of BSA-induced protein tyrosine phosphorylation was successively suppressed by the increased concentration of SERPINE2 (Fig. 6A, lanes 4-7) . Clearly, the characteristic capacitationspecific protein tyrosine phosphorylation pattern induced by BSA was inhibited by SERPINE2.
CTC fluorescence staining is often used to assess capacitation, as judged by the morphology of fluorescently stained sperm. In the control medium without BSA or SERPINE2, sperm showed a spontaneous capacitation rate of approximately 22%. The addition of SERPINE2 significantly decreased the spontaneous capacitation rate to 11%. The population of capacitated sperm remarkably increased (;64%) after the control medium was supplemented with 3 mg/ml BSA. However, SERPINE2 inhibited BSA-induced sperm capacitation significantly after 0.05, 0.1, or 0.2 mg/ml of SERPINE2 was added to BSA-containing medium (Fig.  6B ). These observations are in accordance with the inhibition of BSA-induced tyrosine phosphorylation by SERPINE2 (Fig. 6A) .
Next, we examined the acrosome reaction induced by the calcium ionophore A23187. A spontaneous acrosome reaction was found (15%-26%) with in vitro-capacitated sperm in the incubation medium with or without BSA and/or SERPINE2 (Fig. 6C, white bars) . The concentration of the vehicle used, 0.2% DMSO, did not increase the percentage of acrosomereacted sperm (data not shown). SERPINE2-treated sperm did not show an increased acrosome reaction compared to that of control medium. However, BSA-treated sperm showed remarkable enhancement of the acrosome reaction after A23187 induction. In contrast, the acrosome reaction was significantly inhibited when sperm were incubated with BSA and SERPINE2. An 85% reduction was observed after treatment with 0.2 mg/ml of SERPINE2 (Fig. 6C) . Only capacitated sperm can be induced to undergo an acrosome reaction [37] . Thus, these results further indicated that SERPINE2 is able to inhibit sperm capacitation induced by BSA.
Capacitated sperm can bind to the zona pellucida of oocytes and are induced to undergo an acrosome reaction. If SERPINE2 can inhibit sperm capacitation, this would affect sperm-egg binding and subsequent fertilization. As shown in Figure 7 , epididymal sperm with no treatment had a low capacity to bind to oocytes, with a fertilization rate of approximately 20% in vitro, which may have resulted from fertilization by sperm that reacted to acrosome spontaneously. In contrast, BSA-treated sperm showed strong binding to oocytes and had a higher fertilization rate (;55%-66%). However, supplementation with 0.2 mg/ml SERPINE2 significantly reduced oocyte binding and the fertilization rates of BSA-capacitated epididymal spermatozoa by 82% and 64%, FIG. 6 . Effects of SPERINE2 on murine sperm capacitation. Epididymal spermatozoa were incubated in the presence of 3 mg/ml BSA and/or different concentrations of SERPINE2 at 378C for 90 min. After treatment, the soluble fraction of the sperm lysate was resolved by SDS-PAGE, electrotransferred onto a nitrocellulose membrane, and immunoblotted with anti-phosphotyrosine antibodies (A), or sperm smeared on slides were analyzed by CTC fluorescence staining to score the population of capacitated sperm (B); otherwise, the sperm acrosome reaction induced by the calcium ionophore A23187 (C, black bars) or uninduced (C, white bars) was evaluated by PNA staining (C). A minimum of 200 sperm per trial was evaluated. Data are means 6 SD of three independent experiments. a, significant difference compared to the BSA-only group (P , 0.001); b, significant difference compared to the medium without protein supplementation (P , 0.001).
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respectively. These findings further demonstrated that SER-PINE2 can inhibit BSA-induced sperm capacitation and lead to failure of in vitro fertilization.
BSA is used in most media for sperm capacitation. It is able to promote sperm membrane cholesterol efflux [38] [39] [40] . Cholesterol was released into the medium from BSA-treated sperm, while that release was significantly inhibited by SERPINE2 (Fig. 8A) . SERPINE2-treated sperm retained an amount of cholesterol that was similar to that of untreated sperm (Fig. 8B) .
DISCUSSION
In this study, we demonstrated that the SERPINE2 protein is extensively expressed in apical epithelial cells of male mouse reproductive tissues. It was present in germ cells and was found to be an intrinsic sperm surface protein. Also, more SERPINE2 proteins derived from the seminal plasma bound to ejaculated sperm, and the binding was still detected when sperm had reached the oviduct. Ejaculated sperm in the uterus seemed to be primarily uncapacitated. However, once sperm entered the oviduct, sperm capacitation occurred. Intriguingly, SERPINE2 was detected predominantly on uncapacitated sperm, indicating that SERPINE2 is lost when sperm capacitate. In addition, we demonstrated that exogenous SERPINE2 bound to epididymal sperm and inhibited BSA-induced sperm capacitation in vitro, thus blocking sperm-oocyte interactions. Thus, SERPINE2 possibly exerts its influence on sperm to prevent precocious capacitation and the acrosome reaction before sperm reach the oviduct where fertilization takes place. It is then removed as capacitation occurs. These findings suggest that SERPINE2 is possibly a decapacitation factor.
SERPINE2 antiserum, at a dilution of 1:50, had a maximal effect on epididymal sperm capacitation, with a small increase (14%-19%), compared to that in the control group without protein supplementation in the medium, as demonstrated by CTC fluorescence staining and in vitro fertilization, respectively. However, this slight effect on sperm capacitation was reversed by 0.2 mg/ml SERPINE2 (data not shown). A similar effect was found in a study by Ni et al. [15] . The antisera against HongrES1, a caudal epididymis-specific protein, displayed a more significant increase in guinea pig sperm capacitation, and HongrES1 significantly inhibited the effect [15] . In fact, our preliminary data also showed that BSA capacitation of sperm could be reversed by the addition of 0.2 mg/ml SERPINE2 (data not shown), further supporting the role of SERPINE2 as a decapacitation factor.
Cholesterol efflux is one of the initiation events of sperm capacitation. BSA is a cholesterol acceptor, which induces cholesterol efflux, leading to sperm capacitation [38] [39] [40] . In this study, we revealed that SERPINE2 inhibits BSA-induced cholesterol efflux; the precise mechanism that enables SERPINE2 to retain the cholesterol on the sperm warrants further investigation. SERPINE2 seems to have protective effects toward sperm cultured in vitro by preventing spontaneous capacitation and the acrosome reaction of sperm. As our study demonstrates, the addition of SERPINE2 effectively lowered protein tyrosine phosphorylation levels (Fig. 6A, lanes 1 and 3) , thus yielding a lower percentage of capacitated and acrosome-reacted sperm (Fig. 6, B and C) . Additional evidence for this tendency is the fact that in the presence of SERPINE2, there is a reduced FIG. 7 . Influence of SERPINE2 on sperm-egg interactions. Epididymal spermatozoa were capacitated in BWW medium with BSA and/or SERPINE2 for 90 min and subsequently inseminated with cumulus-intact oocytes for 30 min. Oocytes were gently transferred using a mouth pipette, and we waited 5 min to remove loosely attached sperm from the eggs. Numbers of tightly bound sperm per oocyte were counted (A). Otherwise, treated sperm were inseminated for 6 h to evaluate fertilization (B). Fertilized eggs that showed two pronuclei were identified by Hoechst 33258 staining. Data are means 6 SD from four independent experiments. a, Significant difference compared relative to medium supplemented with BSA (P , 0.001). 522 number of sperm that bind to an egg and a lower fertilization rate than that of the control medium group (Fig. 7) .
Our SERPINE2 antiserum detected two major and one minor SERPINE2 isoforms in the male reproductive tract. A BLASTP search revealed the existence of three SERPINE2 isoforms in the protein database. Many alternatively spliced SERPINE2 gene products can also be seen at the NCBI AceView website (http://www.ncbi.nlm.nih.gov/IEB/Research/ Acembly/). Previous reports have also supported the existence of multiple forms of SERPINE2 protein among mouse tissues [41] .
The Serpine2 mRNA and protein are predominantly expressed in seminal vesicles among mouse tissues [2] . The SERPINE2 protein was previously detected in the epithelium of bovine seminal vesicles and epididymides and in Leydig cells of the testes [27] . However, there is no comprehensive study that has specifically detected this protein in all male reproductive tissues. In this study, we found that if paraffinembedded testicular sections were not treated with the antigen-retrieval solution, then SERPINE2 was immunostained only on Leydig cells (data not shown). However, if the sections were retrieved to unmask the SERPINE2 antigen, staining was detected on spermatogonia, spermatocytes, spermatids, Leydig cells, and spermatozoa (Fig. 3) . This demonstrates the existence of SERPINE2 protein and mRNA in germ cells of adult testes. The Serpine2 mRNA, in fact, exhibits a male-specific expression pattern in developing gonads, suggesting its involvement in a testis-determining pathway [42] .
Plasminogen activators and their cognate inhibitors, including SERPINE1, SERPINE2, SERPINB2, and SERPI-NA5, are all found in mouse testes. The level of Serpina5 mRNA is the highest among them, followed by, respectively, Serpine2, Serpinb2, and Serpine1 mRNA levels [43] . However, murine testicular SERPINE2 seems to have more extensive localization than SERPINA5, as the latter is detected only in Leydig cells before birth and postnatally but is restricted to early spermatids within the acrosomal region in adult testes [44] . SERPINE2 and SERPINA5 are both members of the SERPIN family. Their gene expression levels are regulated by androgen [26, 45] , but they seem to work as counterparts in different species. A comprehensive proteomic study detected only the SERPINA5 protein but not the SERPINE2 protein in human seminal plasma [46] . However, only minor amounts of Serpina5 mRNA were found in other accessory glands of mouse reproductive tissues (our unpublished data), although it was prominently expressed in testes. SERPINE2 was expressed predominantly in the SVS (Fig. 3 ) and contributes to mouse seminal plasma. SERPINE2 would be the major plasminogen activator inhibitor in murine seminal plasma. Interestingly, they are all sperm surface-binding proteins. SERPINA5 binds to human sperm and may influence sperm-oocyte interactions [47] , while SERPINE2 binds to mouse sperm and modulates sperm capacitation (Figs. 6-8) .
PLAU is expressed in mouse seminal vesicles [25] and, thus, is a component of seminal plasma. Its activities were found on ejaculated sperm [25] . The presence of PLAU and SERPINE2 on ejaculated sperm seems to be contradictory because SERPINE2 can inhibit PLAU activity. However, the binding of the SERPINE2 protein to the extracellular matrix (ECM) may alter its inhibitory activity toward PLAU [48] . This might explain the fact that SERPINE2 and PLAU coexist on ejaculated sperm but that the PLAU protein has protease activity. The interplay between the PLAU and SERPINE2 proteins on sperm deserves further investigation.
When ejaculated sperm enter the oviduct, they can bind to the surface of oviductal epithelial cells and are not capacitated at this time. This is well demonstrated in bovines [49] [50] [51] . SERPINE2 is still bound to uncapacitated sperm (Fig. 5) , which are not able to fertilize an egg. SERPINE2-associated sperm may bind to the surface of the murine oviductal epithelium via a heparin-like moiety of ECM. PDC-109, a bovine seminal vesicle secretory protein associated with the plasma membrane of bovine sperm, enables sperm to bind to fucose-binding glycoconjugates on the surface of oviductal epithelial cells [50] . Interestingly, like SERPINE2, PDC-109 is also a heparin-binding protein [52] .
Some protease inhibitors are found on the sperm surface. SERPINA5 is present on the acrosomal surface of human sperm and has been suggested to prevent sperm from prematurely undergoing an acrosomal reaction [47] . SPINK3 was shown to exist on the acrosomal cap of murine sperm and is able to inhibit Ca 2þ uptake by epididymal sperm [23] . A proteinase inhibitor of seminal vesicle origin was shown to block sperm-zona binding and the acrosome reaction [53] . In addition, SPINKL, found mainly on the midpiece, is able to inhibit sperm capacitation [20] . In this study, we showed that SERPINE2, another sperm acrosome-binding protein, also exhibits the ability to inhibit sperm capacitation in vitro. Interestingly, these proteins are all predominantly expressed in seminal vesicles.
SERPINE2 may be like PEBP1 in that it has the dual functions of serving as a decapacitation factor [12] and a serine protease inhibitor [54] . HongrES1, another SERPIN family protein, also displayed similar functions [15, 16] . The inhibitory activity of a serine protease inhibitor and its role as a decapacitation factor might not necessarily be related. SPINKL inhibits sperm capacitation but does not seem to have inhibitory activities against serine proteases [20] . SPINK3 has no effects on sperm capacitation [55] while exhibiting trypsininhibitory activity.
Several heparin-binding proteins are sperm-binding proteins, including lactoferrin [56, 57] , SERPINA5 [47] , and, as shown herein, SERPINE2. Glycosaminoglycans, including heparin, are moieties of the ECM. Sperm were found to possess a surface sialic acid moiety [58] , which is an anionic glycan residue like heparin. Thus, the binding of SERPINA5 and SERPINE2 to sperm may be like the case of protein binding to the ECM to protect sperm from protease attack in the testes and the epididymis during sperm maturation or in the female reproductive tract during transit toward fertilization. Whether they bind to sperm via sialic acid binding awaits further investigation.
In conclusion, we have demonstrated that SERPINE2 is expressed in nearly all of the male reproductive tissues examined, with the largest amount in seminal vesicles. SERPINE2 is intrinsically bound to the plasma membrane overlying the acrosome, while more SERPINE2 proteins derived from the seminal plasma were heavily bound to ejaculated and oviductal sperm in vivo. Nevertheless, SERPINE2 was predominantly detected on uncapacitated sperm, indicating that SERPINE2 is lost during the process of sperm capacitation. Furthermore, supplementation with purified SERPINE2 protein effectively suppressed BSA-induced sperm capacitation in vitro and blocked sperm-oocyte interactions, suggesting that the SERPINE2 protein may play a role as a sperm decapacitation factor. Our study has also demonstrated that SERPINE2 interferes with the capacitationrelated signal transduction machinery by inhibiting cholesterol efflux of sperm. Further studies are warranted to elucidate SERPINE2 IS A POSSIBLE DECAPACITATION FACTOR its other possible mechanisms associated with sperm capacitation.
